CARM (Carisma Therapeutics Inc) Bozor qiymatining balans qiymatiga nisbati
GURU.Markets saytidagi ushbu narxlar grafigi makrofag immunoterapiyasi ishlab chiquvchisi bo'lgan Carisma Therapeutics (CARM) kompaniyasining narxlar dinamikasini aks ettiradi, uning joriy ko'rsatkichi -0.14 darajasida turibdi. Biznes foydani himoya qilish uchun optimallashtirilgan biomaterial yetkazib berish va klinika tarmog'iga tayanadi. Biroq, daromadning yo'qligi va o'smalarni test qilish xarajatlari moliyaviy bosimni keltirib chiqarmoqda, bu esa yashab qolish uchun doimiy tashqi investitsiyalar kirimini taqozo etadi.
%3A%20Sof%20aktivlarga%20nisbatan%20bozor%20kapitallashuvi&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CARM_-_Carisma-Therapeutics_-_Market-Capitalization-to-Net-Assets "CARM Carisma Therapeutics Inc. Bozor kapitallashuvining balans qiymatiga nisbati (28.04.2023 - 25.10.2025) | 👁️GURU.Markets👁️")
Carisma Therapeutics (CARM) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Carisma Therapeutics|CARM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati carismatx.com|CARM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Carisma Tx|CARM - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Carisma Therapeutics
Kompaniyaning dastlabki tahlili:Carisma Therapeutics Inc - CARM
Ushbu koeffitsiyent biznesning bozor qiymatini uning sof kapitaliga solishtirib, aktivlarning haddan tashqari qimmat baholanganlik darajasini aniqlaydi. Investorlar ushbu vositadan bozor anomaliyalarini aniqlash va kapital boshqaruvining samaradorligini solishtirish uchun foydalanadilar. Bozor kapitalizatsiyasining balans hisobotiga nisbatan dinamikasini tahlil qilish orqali investitsiyalarning haddan tashqari qizigan nuqtalarini aniq belgilash mumkin. Carisma Therapeutics (CARM) uchun ushbu ko'rsatkich kompaniyaning ishlanmalari tijoratlashtirilishiga oid bozor kutganlarini aks ettiradi. Mazkur holatda, kompaniyaning qiymati makroiqtisodiy sikllardan ko'ra ko'proq klinik sinovlarning muvaffaqiyati bilan belgilanadi.
Asosiy raqobatchilar
ARGX (argenx SE) - Bozor qiymatining balans qiymatiga nisbati|BNTX (biontech.de) - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga nisbati abivax.com ABVX|Sof aktivlarga nisbatan bozor kapitallashuvi ADMA Biologics Inc|Protagonist Therapeutics Inc (PTGX) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Immunovant Therapeutics (IMVT)|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|grifols.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Adaptive Biotechnologies Corporation (ADPT)|CLDX: Balans qiymatiga nisbatan bozor qiymati|AUPH (Aurinia Pharma) - Bozor qiymatining balans qiymatiga nisbati|BioCryst Corp (BCRX) - Kapitallashuvning sof aktivlarga nisbati|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com (DNTH)|Pharvaris (PHVS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati AbCellera Biologics (ABCL)|Bozor kapitallashuvining balans qiymatiga nisbati TRML|Precigen Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|PHAR: Bozor qiymatining balans qiymatiga nisbati|NKTR: Kapitallashuvning sof aktivlarga nisbati|UPB (Upstream Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|IMNM (Immunome Corp) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati GOSS|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals KALV|Kapitallashuvning balans qiymatiga nisbati septerna.com (SEPN)|PVLA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Savara Inc SVRA|RIGL: Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Kapitallashuvning sof aktivlarga nisbati|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|ENGN (engene.com) - Bozor kapitallashuvining balans qiymatiga nisbati|RAPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Aerovate|ACRS (Aclaris) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi KYTX (Kyverna Therapeutics, Inc)|Bozor qiymatining balans qiymatiga nisbati TLSA|cabalettabio.com - Balans qiymatiga nisbatan bozor kapitallashuvi|VTYX: Bozor qiymatining balans qiymatiga nisbati|THTX - Kapitallashuvning sof aktivlarga nisbati|AVTX: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Eledon Pharmaceuticals, Inc|AGEN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati climbbio.com (CLYM)|Kapitallashuvning sof aktivlarga nisbati Zura Bio|Bozor kapitallashuvining balans qiymatiga multiplikatori aTyr Pharma Inc (ATYR)|Bozor kapitallashuvining balans qiymatiga nisbati Adagene Inc.|Balans qiymatiga nisbatan bozor qiymati ImageneBio IMA|STTK (Shattuck Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|EQ: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati connectbiopharm.com CNTB|Immunic (IMUX) - Balans qiymatiga nisbatan bozor qiymati|ATRA (Atara Biotherapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati IFRX|XFOR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi adicetbio.com (ACET)|CELU: Bozor kapitallashuvining balans qiymatiga nisbati|INMB - Bozor qiymatining balans qiymatiga koeffitsiyenti|Barinthus Bio - Kapitallashuvning sof aktivlarga nisbati|Kezar Life Sciences Inc (KZR) - Bozor kapitallashuvining balans qiymatiga nisbati|SABS - Kapitallashuvning sof aktivlarga nisbati|akaritx.com (AKTX) - Bozor kapitallashuvining balans qiymatiga multiplikatori|ENLV: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Q32 Bio Corp|Bozor kapitallashuvining balans qiymatiga nisbati GOVX (GeoVax Labs Inc)|Kapitallashuvning sof aktivlarga nisbati EDSA (Edesa Biotech Corp)|Bozor qiymatining balans qiymatiga nisbati IBIO|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com XTLB|BOLT: Bozor kapitallashuvining balans qiymatiga nisbati|HCWB - Kapitallashuvning sof aktivlarga nisbati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|AIM (aimimmuno.com) - Bozor kapitallashuvining balans qiymatiga nisbati|ADTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati GRI|Bozor qiymatining balans qiymatiga nisbati XRTX (XORTX Therapeutics)|Kapitallashuvning sof aktivlarga nisbati HIND (Vyome Holdings Inc.)|Revelation Bio (REVB) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Indaptus Corp INDP|Bozor kapitallashuvining balans qiymatiga nisbati Scinai Immunotherapeutics (SCNI)|CALI - Balans qiymatiga nisbatan bozor qiymati|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|ALLK (Allakos) - Bozor kapitallashuvining balans qiymatiga nisbati|HOOK - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati IGMS|Bozor qiymatining balans qiymatiga nisbati ITOS (iTeos Therapeutics)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com (OCEA)|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|THRD - Bozor kapitallashuvining balans qiymatiga nisbati